Clyde Biosciences Ltd.
About Clyde Biosciences Ltd.
Clyde Biosciences is a leading global cardiac safety service provider. Our speciality is in the assessment of cardiotoxicity potential for the global pharmaceutical industry. We work with:
- Safety Pharmacology
- Cardiovascular Therapeutics
- Leading Stem Cell Suppliers
Our technology was developed in... Show more »
Clyde Biosciences is a leading global cardiac safety service provider. Our speciality is in the assessment of cardiotoxicity potential for the global pharmaceutical industry. We work with:
- Safety Pharmacology
- Cardiovascular Therapeutics
- Leading Stem Cell Suppliers
Our technology was developed in the laboratory of Professor Godfrey Smith (Chief Scientific Officer, Clyde Biosciences) a world-leading cardiac scientist with 25+ years experience in cardiac electrophysiology research. Clyde’s CellOPTIQ® platform delivers reliable, high resolution functional output from a range of cardiac cell types including iPS-derived heart cells. High bandwidth membrane voltage signals from CellOPTIQ® provides new insights into electrophysiological effects of drugs. Rapid data capture and analysis is made possible by our bespoke software which allows accelerated assay throughput in a 96 well format.
Our Services (15)
In vitro Cardiotoxicity Screening
In vitro cardiotox using iPS cardiomyocytes on a voltage sensitive dye platform. Voltage, calcium contraction studies.
In vitro cardiotox using iPS cardiomyocytes on a voltage sensitive dye platform. Voltage, calcium contraction studies.
Comprehensive in vitro Proarrhythmia Assay (CiPA)
Clyde Biosciences is an official member of the CiPA consortium, and a Core Group member contributing towards the development of the next generation of assays.
We run drug screening studies on our CellOPTIQ® system using the accepted CiPA Protocol. Only Clyde can provide you with a rapid-turnaround VSD screening study on your... Show more »
Clyde Biosciences is an official member of the CiPA consortium, and a Core Group member contributing towards the development of the next generation of assays.
We run drug screening studies on our CellOPTIQ® system using the accepted CiPA Protocol. Only Clyde can provide you with a rapid-turnaround VSD screening study on your compounds.
Clyde works with virtually all of the major suppliers of iPS-CMs to characterise their cells on using the standard CiPA protocol. These data provide an invaluable reference point for the performance of cells. CellOPTIQ® works with 2D and 3D structures.
Major benefits include:
- Drug screening using a standard CiPA protocol
- iPS-CM characterisation studies using CiPA 8 (first phase CiPA)
- iPS-CM characterisation studies using CiPA 28 (second phase CiPA)
Stem Cell Analysis
Clyde Biosciences works with the leading manufacturers of iPS-CMs to provide a broad dataset of parameters, enabling companies to understand the performance of their cells in the context of drug testing.
These data are essential for iPS-CM suppliers to communicate accurately the characteristics of their cells to biopharma... Show more »
Clyde Biosciences works with the leading manufacturers of iPS-CMs to provide a broad dataset of parameters, enabling companies to understand the performance of their cells in the context of drug testing.
These data are essential for iPS-CM suppliers to communicate accurately the characteristics of their cells to biopharma companies.
Clyde’s Approach:
- Clyde Biosciences’ CellOPTIQ™ system measures calcium, voltage and contractility in the same cells
- Using ratiometric dyes, CellOPTIQ™ can make measurements which are unaffected by movement artefact or variations in cell thickness
- This means data are more accurate, with significantly reduced signal-to-noise
Ion Channel Screening Assays
Clyde is able to provide our clients with access to the highest quality ion channel screening technology
Clyde’s Ion Channel Service:
The Rational Approach
- Clyde partners with the industry’s leading specialist ion channel providers
- Provide CiPA-ready data combining outputs from all assay modalities in one project
Clyde is able to provide our clients with access to the highest quality ion channel screening technology
Clyde’s Ion Channel Service:
The Rational Approach
- Clyde partners with the industry’s leading specialist ion channel providers
- Provide CiPA-ready data combining outputs from all assay modalities in one project
Induced Pluripotent Stem Cell Lines
hiPSC-CM - Human induced pluripotent stem cell-derived cardiomyocytes
hiPSC-CM - Human induced pluripotent stem cell-derived cardiomyocytes
Mammalian Cell Culture
Cell-Based Assays
Cells and Tissues
Biology
Drug Discovery & Development
Drug Discovery & Development Services
Drug Discovery & Development Services
Toxicology
Toxicology Services
Toxicology Services
In vitro Toxicity Testing
In vitro Toxicity Testing Services
In vitro Toxicity Testing Services
Pharmacology & Toxicology
In vitro Ion Channel Assays
Cell Lines
Not finding what you're looking for?
Get info on this provider's capabilities without requesting a quote.Clyde Biosciences Ltd. has not received any reviews.
Clyde Biosciences Ltd. has not received any endorsements.